Next Generation News and Research

RSS

Ground-breaking computer models raise the bar for sporting achievement

Computer models now under development could enhance the design of sports equipment to help people of all abilities realise their sporting potential.

13 Sep 2007

A molecular probe that may one day light up tumors while surgery is in progress

Researchers at the Stanford University School of Medicine have developed a molecular probe that sets aglow tumor cells within living animals. Their goal is to use the probe to improve the diagnosis and treatment of cancer and other diseases.

10 Sep 2007

Autoimmune response, triggered by genes, can be a barrier to producing a viable offspring

Plant biologists at the Max Planck Institute of Developmental Biology and the University of North Carolina at Chapel Hill have discovered that an autoimmune response, triggered by a small number of genes, can be a barrier to producing a viable offspring.

4 Sep 2007

New phages to treat bacterial diseases

Viruses found in the River Cam in Cambridge, famous as a haunt of students in their punts on long, lazy summer days, could become the next generation of antibiotics, according to scientists speaking today (Monday 3 September 2007) at the Society for General Microbiology's 161st Meeting at the University of Edinburgh, UK, which runs from 3-6 September 2007.

3 Sep 2007

Abbott and AstraZeneca confirm Phase III clinical trials of Fenofibrate ABT-335 and Crestor as fixed-dose combination

Abbott and AstraZeneca confirmed they will advance the development of Abbott's next-generation fenofibrate ABT-335 and AstraZeneca's CRESTOR (rosuvastatin calcium) in a fixed-dose combination treatment into Phase III clinical trials.

3 Sep 2007

One species' entire genome discovered inside another's

Scientists at the University of Rochester and the J. Craig Venter Institute have discovered a copy of the entire genome of a bacterial parasite residing inside the genome of its host species.

30 Aug 2007

Evolution may have sped up

Is heading straight for a goal the quickest way there? If the name of the game is evolution, suggests new research at the Weizmann Institute of Science, the pace might speed up if the goals themselves change continuously.

29 Aug 2007

Human testes may act as mutation multipliers

The testes in humans may act as mutation multipliers that raise the odds of passing improved DNA to offspring - but that can also backfire by increasing the frequency of certain diseases.

28 Aug 2007

Computer simulation shows how evolution may have speeded up

28 Aug 2007

Scientist uses novel mass spectrometer to weigh virus particle

With unprecedented sensitivity, Carnegie Mellon University's Mark Bier has characterized large viral particles and bulky von Willebrand factors using a novel mass spectrometer.

24 Aug 2007

Breakthrough pain medication

Cancer patients frequently experience two types of pain: persistent and breakthrough.

17 Aug 2007

Bcl-3 protein regulates inflammation by blocking ubiquitination

Researchers at the University of Pennsylvania School of Medicine recently identified how a regulatory protein called Bcl-3 helps to control the body's inflammation response to infection by interfering a critical biochemical process called ubiquitination.

8 Aug 2007

New tool for use in addressing lead poisoning

Lead in goat blood might not be on the top of your shopping list, but for U.S. medical personnel who each year perform more than 2 million human blood measurements, Standard Reference Material (SRM) 955c from the National Institute of Standards and Technology (NIST) can't be beat.

6 Aug 2007

Discovery of molecular pathway that detects and eliminates defective messenger RNAs from red blood cells

Other such pathways - known as surveillance pathways - operate in a more general way, in many cell types. Knowing how this specific surveillance system works can help researchers better understand hereditary diseases, in this case, thalassemia, a form of anemia, which is the most common genetic disorder worldwide.

3 Aug 2007

Active management of risk in pregnancy lowers Cesarean rates

At a time when national rates of cesarean delivery have climbed above 30%, a four-year study of patients receiving an alternative method of obstetric care experienced a significantly lower rate of cesarean births, according to a study published in the current issue of the Annals of Family Medicine .

1 Aug 2007

FDA approves Demipulse and Demipulse Duo Generators for use in vagus nerve stimulation

Cyberonics, Inc. has announced that the Demipulse and Demipulse Duo Generators for use in Vagus Nerve Stimulation ("VNS") Therapy were approved by the United States Food and Drug Administration ("FDA") for commercial release.

17 Jul 2007

New target for muscular dystrophy drug therapy

Researchers at the University of Pennsylvania School of Medicine report how the gene for utrophin, which codes for a protein very similar to dystrophin, the defective protein in Duchenne muscular dystrophy (DMD), puts the brakes on its own expression in muscle cells, thereby suggesting a new target for treatment.

13 Jul 2007

Wilmot Cancer Center studies new chemo pill for lymphoma

Doctors at the University of Rochester's James P. Wilmot Cancer Center are first in the world to study a new, targeted agent that zeroes-in on B-cell lymphomas. The new twice-a-day pill offers patients with recurrent disease another choice as their options grow thin.

12 Jul 2007

Microchip Biotechnologies secures patent rights from Pathwork Diagnostics

Microchip Biotechnologies, Inc. has announced that it has secured key patent rights from Pathwork Diagnostics for sample injection structures in microfluidic separations.

12 Jul 2007